Message
[X]
Error
[X]
Confirm
[X]
Input
[X]

Dr Ong Tee Chuan

Dr Ong Tee Chuan

Dr Ong Tee Chuan

Designation

Chairperson for Blood & Marrow Transplant (Adults) chapter of National
Transplant Registry

Institution

Hospital Ampang

Qualification

1. MBBS (Universiti Malaya) 1996
2. MRCP (UK) 2000

Special field of interest

Blood & Marrow Transplant (Adults)

Abstract

Title: COVID in HSCT and Haemato-oncology Patients
Body: Covid-19 pandemic results in serious mortality and morbidity worldwide, patients with hematological malignancies are the most severely affected cohort, in addition to greatly elevated risk of severe Covid-19 and high mortality, the pandemic has affected the timely diagnosis, treatment and follow-up in hematological malignancy. There are still inadequate big randomized clinical trials to guide scientifically proven management plan for this group of patients, many recommendations are extrapolated from data and clinical trials of non-cancer population, in addition to logical inference from the understanding of immunological dysregulation and pathophysiology of Covid-19. With more experience and information coming in, Hematologists must use existing and updated data to plan and manage patients with hematological malignancies to achieve the balance between inadequate treatment of underlying disease and predispose patients to more severe Covid-19 if they are infected during treatment.
  (51.16 KB)

Platinum

Gold

Silver

Bronze

Others

In collaboration with :